Kenvue Inc. demonstrates a stable performance as a consumer health company entrenched in essential products. Although relatively new since its incorporation in 2022, it benefits from strong brand recognition through its parent company, Johnson & Johnson. Investors should watch its fundamental scores which show potential, though analyst sentiment is currently neutral.
The fundamental analysis marks Kenvue Inc. with a stable B+ rating, indicating steady performance driven by strong cash flow and equity returns.
| Category | Score | Visualization |
|---|---|---|
| Discounted Cash Flow | 5 | |
| Return on Equity | 4 | |
| Return on Assets | 4 | |
| Debt to Equity | 2 | |
| Price to Earnings | 2 | |
| Price to Book | 2 |
The historical ratings show consistent scoring, reflecting the company's steady financial strategy and market position over time.
| Date | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|
| 2026-06-05 | 3 | 5 | 4 | 4 | 2 | 2 | 2 |
| Latest | 0 | 5 | 4 | 4 | 2 | 2 | 2 |
Analyst target prices suggest a stable outlook with close-knit high, low, and median values, highlighting Kenvue's consistent market perceptions.
| High | Low | Median | Consensus |
|---|---|---|---|
| 19 | 18 | 18 | 18.25 |
The analyst sentiment is neutrally skewed towards holding the stock, with a significant number of Hold recommendations.
| Recommendation | Number | Percentage |
|---|---|---|
| Strong Buy | 0 | |
| Buy | 4 | |
| Hold | 10 | |
| Sell | 0 | |
| Strong Sell | 0 |
Kenvue Inc. presents itself as a reputable investment option predominantly in the consumer health segment. Its fundamental metrics are promising, especially with regards to cash flow and equity returns, though some risks exist in valuation metrics like Debt to Equity and Price to Book ratios. The stable stock price targets and hold consensus further emphasize a cautious yet optimistic outlook. Investors should weigh these elements carefully, considering the larger economic backdrop and market conditions. Continued attention to the company's financial health and strategic positioning in its industry will be crucial.
Don't leave your profits to chance. Historically, this stock follows specific seasonal patterns that institutional traders use to maximize returns.